190 related articles for article (PubMed ID: 26715308)
1. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
Ohyama A; Higashi T; Motoyama K; Arima H
Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
[TBL] [Abstract][Full Text] [Related]
2. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
[TBL] [Abstract][Full Text] [Related]
3. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
[TBL] [Abstract][Full Text] [Related]
4. Ternary complexes of folate-PEG-appended dendrimer (G4)/α-cyclodextrin conjugate, siRNA and low-molecular-weight polysaccharide sacran as a novel tumor-selective siRNA delivery system.
Ohyama A; Higashi T; Motoyama K; Arima H
Int J Biol Macromol; 2017 Jun; 99():21-28. PubMed ID: 28223132
[TBL] [Abstract][Full Text] [Related]
5. In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate.
Mohammed AFA; Higashi T; Motoyama K; Ohyama A; Onodera R; Khaled KA; Sarhan HA; Hussein AK; Arima H
AAPS J; 2019 Apr; 21(4):54. PubMed ID: 30993472
[TBL] [Abstract][Full Text] [Related]
6. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
Hayashi Y; Higashi T; Motoyama K; Mori Y; Jono H; Ando Y; Arima H
J Drug Target; 2013 May; 21(5):487-96. PubMed ID: 23570609
[TBL] [Abstract][Full Text] [Related]
8. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
[TBL] [Abstract][Full Text] [Related]
9. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis.
Motoyama K; Mitsuyasu R; Akao C; Abu Hashim II; Sato N; Tanaka T; Higashi T; Arima H
Mol Pharm; 2015 Sep; 12(9):3129-36. PubMed ID: 26270769
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.
Hayashi Y; Higashi T; Motoyama K; Jono H; Ando Y; Onodera R; Arima H
Biol Pharm Bull; 2019; 42(10):1679-1688. PubMed ID: 31582656
[TBL] [Abstract][Full Text] [Related]
11. Recent Findings Concerning PAMAM Dendrimer Conjugates with Cyclodextrins as Carriers of DNA and RNA.
Arima H; Motoyama K
Sensors (Basel); 2009; 9(8):6346-61. PubMed ID: 22454589
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression.
Arima H; Tsutsumi T; Yoshimatsu A; Ikeda H; Motoyama K; Higashi T; Hirayama F; Uekama K
Eur J Pharm Sci; 2011 Oct; 44(3):375-84. PubMed ID: 21896329
[TBL] [Abstract][Full Text] [Related]
13. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
[TBL] [Abstract][Full Text] [Related]
15. Potential use of fucose-appended dendrimer/α-cyclodextrin conjugates as NF-κB decoy carriers for the treatment of lipopolysaccharide-induced fulminant hepatitis in mice.
Akao C; Tanaka T; Onodera R; Ohyama A; Sato N; Motoyama K; Higashi T; Arima H
J Control Release; 2014 Nov; 193():35-41. PubMed ID: 25020038
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.
Motoyama K; Mitsuyasu R; Akao C; Tanaka T; Ohyama A; Sato N; Higashi T; Arima H
AAPS J; 2014 Nov; 16(6):1298-308. PubMed ID: 25236864
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.
Abdelwahab AF; Ohyama A; Higashi T; Motoyama K; Khaled KA; Sarhan HA; Hussein AK; Arima H
J Drug Target; 2014 Dec; 22(10):927-34. PubMed ID: 25148608
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
Tsutsumi T; Hirayama F; Uekama K; Arima H
J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
[TBL] [Abstract][Full Text] [Related]
19. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
Kim SH; Mok H; Jeong JH; Kim SW; Park TG
Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
